Literature DB >> 23377860

Estimation of parameters for the elimination of an orally administered test substance with unknown absorption.

Josef A Vogt1, Christian Denzer.   

Abstract

Assessment of the elimination of an oral test dose based on plasma concentration values requires correction for the effect of gastric release and absorption. Irregular uptake processes should be described 'model independently', which requires estimation of a large number of absorption parameters. To limit the associated computational effort a new approach is developed with a reduced number of unknown parameters. A marginalized and regularized absorption approach (MRA) is defined, which uses for the uptake just one parameter to control rigidity of the uptake curve. For validation, elimination and absorption were reproduced using published IVIVC data and a synthetic data set for comparison with approaches using a 'model-free'--staircase function or mechanistic models to describe absorption. MRA performed almost as accurate as well specified mechanistic models, which gave the best reproduction. MRA demonstrated a 50fold increase in computational efficiency compared to other approaches. The absorption estimated for the IVIVC study demonstrated an in vivo-in vitro correlation comparable to published values. The newly developed MRA approach can be used to efficiently and accurately estimate elimination and absorption with a restricted number of adaptive parameters and with automatic adjustment of the complexity of the uptake.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377860     DOI: 10.1007/s10928-013-9299-z

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  15 in total

1.  Time-dependent oral absorption models.

Authors:  K Higaki; S Yamashita; G L Amidon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-04       Impact factor: 2.745

Review 2.  Pharmacokinetic strategies in deciphering atypical drug absorption profiles.

Authors:  Honghui Zhou
Journal:  J Clin Pharmacol       Date:  2003-03       Impact factor: 3.126

3.  The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Authors:  Chantal Csajka; David Drover; Davide Verotta
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

4.  Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.

Authors:  Radojka M Savic; Daniël M Jonker; Thomas Kerbusch; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-07-26       Impact factor: 2.745

5.  A semiparametric method for describing noisy population pharmacokinetic data.

Authors:  K Park; D Verotta; T F Blaschke; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

6.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.

Authors:  K Iga; Y Ogawa; T Yashiki; T Shimamoto
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

7.  A note on the rôle of generalized inverse Gaussian distributions of circulatory transit times in pharmacokinetics.

Authors:  M Weiss
Journal:  J Math Biol       Date:  1984       Impact factor: 2.259

8.  Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.

Authors:  G E Blakey; I A Nestorov; P A Arundel; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

9.  Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).

Authors:  Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G Richard Granneman
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

10.  Dose dependent absorption and linear disposition of cyclosporin A in rat.

Authors:  A Lindberg-Freijs; M O Karlsson
Journal:  Biopharm Drug Dispos       Date:  1994-01       Impact factor: 1.627

View more
  1 in total

1.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.